Alkem Laboratories Ltd
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Glucoryl-MV 2/0.3 Tablet SR is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Glucoryl-MV 2/0.3 Tablet SR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glucoryl-MV 2/0.3 Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glucoryl-MV 2/0.3 Tablet SR.
Glucoryl-MV 2/0.3 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glucoryl-MV 2/0.3 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glucoryl-MV 2/0.3 Tablet SR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain loss of appetite or yellowing of the eyes or skin (jaundice).
Glucoryl-MV 2/0.3 Tablet SR is a combination of Glimepiride, Metformin and Voglibose used for the treatment of Type 2 Diabetes Mellitus (DM). It improves blood glucose levels in adults when taken with proper diet and regular exercise. Glimepiride lowers blood glucose by increasing insulin release from the pancreas. Metformin reduces glucose production in the liver and enhances insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meals) glucose levels.
Common side effects include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
Avoid this medication if you have an allergy to any of its ingredients or excipients, moderate to severe kidney disease, inflammatory bowel disease, colonic ulcers, or underlying metabolic acidosis including diabetic ketoacidosis.
No, Alcohol consumption with this medication is not advisable. It can lower blood sugar levels and increase the risk of lactic acidosis.
Yes, it may cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It's more common if you miss meals, drink alcohol, over-exercise, or take other antidiabetic medications alongside it. Regular monitoring of blood glucose is crucial.
Store in its original container, tightly closed, following the instructions on the pack label. Dispose of unused medication safely and out of reach of children, pets, and others.